Skip to search formSkip to main contentSkip to account menu

Hyperphenylalaninemia, Non-Phenylketonuric

Known as: Deficiency, Tetrahydrobiopterin, Non Phenylketonuric Hyperphenylalaninemia, Tetrahydrobiopterin Deficiency 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
The ammonia complex of magnesium borohydride Mg(BH4)2.2NH3 (I), which contains 16.0 wt % hydrogen, is a potentially promising… 
Highly Cited
2007
Highly Cited
2007
Background— Tetrahydrobiopterin (BH4) deficiency is reported to uncouple the enzymatic activity of endothelial nitric oxide… 
Highly Cited
2004
Highly Cited
2004
A novel therapeutic strategy for phenylketonuria (PKU) has been initiated in Japan. A total of 12 patients who met the criteria… 
Highly Cited
2000
Highly Cited
2000
Endothelial cells (EC) from diabetic BioBreeding (BB) rats have an impaired ability to produce NO. This deficiency is not due to… 
Highly Cited
2000
Highly Cited
2000
To investigate the role of tetrahydrobiopterin (BH4) in the catalytic mechanism of nitric oxide synthase (NOS), we analyzed the… 
Highly Cited
1999
Highly Cited
1999
Since 1998, the NSW Newborn Screening Program has used electrospray tandem mass spectrometry (MS/MS) to analyse samples from all… 
Highly Cited
1997
Highly Cited
1997
In hypercholesterolemia, impaired nitric oxide activity has been associated with increased nitric oxide degradation by oxygen…